ArticleAmerican journal of translational research2016

Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling.

Sida Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.